Cargando…
The miR-142 Suppresses U-87 Glioblastoma Cell Growth by Targeting EGFR Oncogenic Signaling Pathway
Glioblastoma is the most lethal malignancy of the brain and is resistant to conventional cancer treatments. Gene-therapy approaches like using tumor suppressor miRNAs are promising in the treatment of glioblastoma. They control the expression of oncogenes and influence tumor features and behaviors....
Autores principales: | Gheidari, Fatemeh, Arefian, Ehsan, Jamshidi Adegani, Fatemeh, Fallah Atanaki, Fereshteh, Soleimani, Masoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842594/ https://www.ncbi.nlm.nih.gov/pubmed/35194440 http://dx.doi.org/10.22037/ijpr.2021.115089.15193 |
Ejemplares similares
-
miR-548x and miR-4698 controlled cell proliferation by affecting the PI3K/AKT signaling pathway in Glioblastoma cell lines
por: kalhori, Mohammad Reza, et al.
Publicado: (2020) -
MicroRNA-129 Inhibits Glioma Cell Growth by Targeting CDK4, CDK6, and MDM2
por: Moradimotlagh, Atieh, et al.
Publicado: (2019) -
Differentiation MicroRNAs Affect Stemness Status of USSCs
por: Jamshidi Adegani, F, et al.
Publicado: (2011) -
Ceramide Is Involved in Temozolomide Resistance in Human Glioblastoma U87MG Overexpressing EGFR
por: Bassi, Rosaria, et al.
Publicado: (2023) -
Expression Change of miR-214 and miR-135 during
Muscle Differentiation
por: Honardoost, Maryam, et al.
Publicado: (2015)